A23V2200/302

TRIVALENT AND DIVALENT CATIONS AS ADMINISTRABLE AGENTS FOR INCREASED PROCESSIVITY AND IMPROVED FIDELITY OF REVERSE TRANSCRIPTASE IN TELOMERASE AND IN NUCLEIC ACID POLYMERASES
20200197351 · 2020-06-25 ·

A novel method of increasing longevity by improving the processivity, fidelity, and activity of the telomerase enzyme is provided by agents which introduce trivalent cations such as scandium 3+ into the nuclei of cells, whereupon there occurs substitution of the trivalent cation into the place of the natural divalent cations such as magnesium or calcium or manganese. This substitution optimizes the adherence of the telomerase enzyme to its nucleic acid template with the result that cellular replicative senescence is delayed and deferred in various cell types. The trivalent cations can be introduced topically, orally as a food additive or supplement, or as a medication for oral, intramuscular, intrathecal or intravenous administration.

LIFE-EXTENDING AGENT, ANTI-AGING AGENT, COSMETIC, AND FOOD/BEVERAGE COMPOSITION

This invention provides a life-extending agent comprising at least one member selected from the group consisting of D-proline, D-hydroxyproline, and D-aspartic acid.

LIFE-EXTENDING AGENT, ANTI-AGING AGENT, COSMETIC, AND FOOD/BEVERAGE COMPOSITION

This invention provides a life-extending agent comprising at least one member selected from the group consisting of D-proline, D-hydroxyproline, and D-aspartic acid.

LIQUID FOOD COMPOSITION COMPRISING SOPHORA JAPONICA EXTRACT

The present invention relates to a liquid food composition comprising a Sophora japonica and a broad-leaf bamboo extract, and more particularly, to a liquid food composition including a Sophora japonica extract, a broad-leaf bamboo extract, and xanthan gum. The liquid food composition includes a high content of the Sophora japonica extract while simultaneously ensuring the liquid properties, and thus can be used widely in the field of foods because the liquid food composition is applicable to liquid formulations.

LIQUID FOOD COMPOSITION COMPRISING SOPHORA JAPONICA EXTRACT

The present invention relates to a liquid food composition comprising a Sophora japonica and a broad-leaf bamboo extract, and more particularly, to a liquid food composition including a Sophora japonica extract, a broad-leaf bamboo extract, and xanthan gum. The liquid food composition includes a high content of the Sophora japonica extract while simultaneously ensuring the liquid properties, and thus can be used widely in the field of foods because the liquid food composition is applicable to liquid formulations.

Mangifera indica as a Sirtuin 1 activating agent

The invention relates to a Mangifera (Mango) Indica preparation as Sirtuin 1 activating agent for in vivo and in vitro applications. The preparation may be used to reduce the risk of developing obesity, type II diabetes, elevated blood lipid levels, artheriosclerosis and cardiovascular diseases, as well as a cell and DNA protector.

Mangifera indica as a Sirtuin 1 activating agent

The invention relates to a Mangifera (Mango) Indica preparation as Sirtuin 1 activating agent for in vivo and in vitro applications. The preparation may be used to reduce the risk of developing obesity, type II diabetes, elevated blood lipid levels, artheriosclerosis and cardiovascular diseases, as well as a cell and DNA protector.

Freedom
20200060320 · 2020-02-27 · ·

Freedom is a nutritional supplement designed to combat inflammation. It combines the eight most researched anti-inflammatory natural compounds into a single supplement.

Freedom
20200060320 · 2020-02-27 · ·

Freedom is a nutritional supplement designed to combat inflammation. It combines the eight most researched anti-inflammatory natural compounds into a single supplement.

Composition, For Remedying Female Climacteric Syndrome Symptoms, Comprising Tectorigenin 7-O-Xylosylglucoside

The present disclosure relates to a composition for preventing, treating or remedying female climacteric syndrome symptoms, which contains tectorigenin 7-O-xylosylglucoside. The composition according to the present disclosure shows quick effects for preventing, remedying and/or treating female climacteric syndrome symptoms, particularly facial flushing and/or osteoporosis, and thus can be utilized for the hormone replacement therapy (HRT) used for preventing or remedying climacteric syndrome symptoms.